Ambey Laboratories Limited (NSE:DHANSA)

Market Cap	623.67M -43.6%
Revenue (ttm)	1.43B +7.5%
Net Income	55.23M +15.5%
EPS	2.21 +7.4%
Shares Out	24.95M
PE Ratio	11.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	26.25
Previous Close	n/a
Day's Range	25.00 - 26.25
52-Week Range	16.20 - 48.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Ambey Laboratories

Ambey Laboratories Limited manufactures and distributes agro chemicals and home hygiene products in India. The company offers 2,4-D acid tech, sodium salt, amine salt, ethyl hexyl ester tech, and ethyl ester tech; and chlorpyriphos, thiamethoxam, pretilachlor, metribuzin, hexaconazole, clodinofob tech, and lambda cyhalothrine tech. It also exports its products. Ambey Laboratories Limited was incorporated in 1985 and is based in Gurugram, India.

• Industry: Agricultural Chemicals
• Founded: 1985
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: DHANSA

Financial Performance

In fiscal year 2026, Ambey Laboratories's revenue was 1.43 billion, an increase of 7.48% compared to the previous year's 1.33 billion. Earnings were 55.23 million, an increase of 15.47%.